Results for tag: "Bioresorbable Scaffold"

The Bioresorbable Scaffold (BRS) market is a subset of the larger biomaterials market. BRS are medical devices used to treat coronary artery disease, and are designed to be absorbed by the body over time. They are made of biodegradable polymers, such as polylactic acid, and are designed to provide temporary support to the artery wall while the body heals. BRS are used to treat coronary artery disease, and can also be used to treat peripheral artery disease, and other vascular diseases. BRS are becoming increasingly popular due to their ability to provide temporary support to the artery wall, while allowing the body to heal naturally. Additionally, BRS are less invasive than traditional treatments, and can reduce the risk of complications associated with traditional treatments. Some companies in the BRS market include Abbott, Biotronik, Boston Scientific, Medtronic, and Terumo. Show Less Read more